Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The malignant clone in Waldenstrom's macroglobulinemia.

Jitra Kriangkum1, Brian J Taylor, Michael J Mant

  • 1Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.

Seminars in Oncology
|April 30, 2003
PubMed
Summary

Monitoring clonotypic IgM is crucial for accurately identifying Waldenstrom's macroglobulinemia (WM) cells. This unique marker, found in most WM patients, distinguishes malignant cells from polyclonal B cells in blood and bone marrow.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors for Violence in Adult Heterosexual Noncasual Relationships: An Overview of Reviews.

Trauma, violence & abuse·2025
Same author

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings.

Frontiers in immunology·2025
Same author

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia.

American journal of hematology·2024
Same author

Editorial Expression of Concern: Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.

Oncogene·2024
Same author

Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial.

Future oncology (London, England)·2024
Same author

Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.

Nature medicine·2024

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Waldenstrom's macroglobulinemia (WM) is a rare B-cell lymphoproliferative disorder.
  • Identifying the malignant clone is essential for diagnosis and monitoring.

Purpose of the Study:

  • To characterize the unique IgM VDJ sequence (clonotypic) in WM patients.
  • To evaluate the utility of clonotypic IgM monitoring for disease assessment.

Main Methods:

  • Identification of clonotypic IgM VDJ sequences in 12 WM patients.
  • Detection of clonotypic IgM transcripts in blood and bone marrow.
  • Phenotypic analysis of B cells (CD20+, CD138+) and IgD expression.

Main Results:

  • The majority (92%) of WM patients possessed clonotypic IgM from the VH3 family with long CDR3 regions.

Related Experiment Videos

  • Clonotypic IgM transcripts were found in both blood and bone marrow, indicating a blood-borne component.
  • Phenotypic B-cell identification alone was insufficient for monitoring disease progression, as seen in one patient with increased polyclonal B cells despite decreased malignant cell markers.

    • Conclusions:

    • Clonotypic IgM sequencing is a highly accurate method for identifying the malignant clone in WM.
    • Monitoring clonotypic IgM transcripts provides a reliable means to distinguish WM cells from polyclonal B cells.
    • Phenotypic analysis of circulating B cells is inadequate for effective WM disease monitoring.